Stay updated with breaking news from Evogene Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com assumed coverage on shares of Evogene (NASDAQ:EVGN – Free Report) in a research note published on Sunday. The brokerage issued a sell rating on the biotechnology company’s stock. Evogene Price Performance Shares of EVGN stock opened at $0.77 on Friday. The company has a market capitalization of $31.73 million, a PE ratio of -1.67 […]
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF...
Conference call and webcast: today, May 23, 2024, 9:00 am ET Financial and Business Highlights: Q1 2024 revenue: $4.2M vs. $0.6M in Q1 2023; anticipating...
Conference call and webcast: today, May 23, 2024, 9:00 am ET Financial and Business Highlights: Q1 2024 revenue: $4.2M vs. $0.6M in Q1 2023; anticipating continued growth in 2024. Q1 2024 net loss:...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF...